Riskpilot← Back to searchSign inGet full accessSuomen Bionatura Oy
OYDissolvedY-tunnus 0484081-6Majurinkatu 17-A34Retail sale of other food · NACE 4727Est. 19821 employees
Revenue 2025
EUR 50K
-99% vs 2024
EBITDA margin
-38.7%
-117% vs 2024
Equity ratio
-156376.5%
Financial strength
Net profit 2025
EUR -23K
-1433% vs 2024
| Revenue | EUR 50K | -99% |
| EBITDA | EUR -19K | -117% |
| Net profit | EUR -23K | -1433% |
| Total assets | EUR 17 | -100% |
| Equity | EUR -27K | -683% |
| Employees | 1 | — |
Legal name
Suomen Bionatura Oy
Y-tunnus number
0484081-6
Legal form
Osakeyhtiö
NACE code
4727 · Retail sale of other food
Founded
18. elokuuta 1982
Share capital
EUR 11 078
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on, lähinnä vegetaaristen ja luontaistuotteiden, sekä terveyttä edistävien tuotteiden ja elintarvikkeiden myynti, tuonti, vienti ja valmistus. Yhtiö voi harjoittaa tämän alan konsultointia ja aineettomien oikeuksien hyödyntämistä. Yhtiö voi toimintaansa varten omistaa kiinteistöjä ja arvopapereita.
Address
Majurinkatu 17-A34
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 164 | 88 | 82 | 7 989 | 50 |
| Staff expenses | −38 | −13 | −3 | −388 | −3 |
| EBITDA | −12 | −11 | 12 | 115 | −19 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | −12 | −11 | 12 | 115 | −19 |
| Net financials | −2 | −6 | −2 | −3 | −4 |
| Profit before tax | −14 | −17 | 9 | −2 | −23 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −14 | −17 | 9 | −2 | −23 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 21 | 17 | 2 767 | 26 | 0 |
| Equity | 6 | −11 | −2 | −3 | −27 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 16 | 28 | 2 955 | 30 | 27 |
| Total debt | 16 | 28 | 2 955 | 30 | 27 |
EBITDA margin
-38.7%
This company
15.8%
Market median
-345% vs market
20212025
Equity ratio
-156376.5%
This company
38.2%
Market median
-409463% vs market
20212025
Return on equity
-2318700.0%
This company
18.4%
Market median
-12601730% vs market
20212025
Net profit margin
-46.6%
This company
8.1%
Market median
-675% vs market
20212025
Asset turnover
2928.65×
This company
1.12×
Market median
+261387% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KI Chief Executive Officer | Chief Executive Officer | 2019 |
JT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2019 |
| Former (1) | ||
HK Chief Executive Officer | Chief Executive Officer | 2002 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2002 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Suomen Bionatura Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katja Irene Kelaranta | Chief Executive Officer | 0 companies |
| Hans Konstantin Helenius | Chief Executive Officer | 0 companies |
| Jouni Tapani Kelaranta | Deputy Chief Executive Officer | 0 companies |
| Liisa Helmi Kaarina Helenius | Board of Directors | 0 companies |